These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 14560574

  • 41. T-cell prolymphocytic leukemia: an aggressive T cell malignancy with frequent cutaneous tropism.
    Magro CM, Morrison CD, Heerema N, Porcu P, Sroa N, Deng AC.
    J Am Acad Dermatol; 2006 Sep; 55(3):467-77. PubMed ID: 16908353
    [Abstract] [Full Text] [Related]

  • 42. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D, Cao Y, Luetkens T, Panse J, Faltz C, Arfsten J, Bartels K, Wolschke C, Eiermann T, Zander AR, Fehse B, Bokemeyer C, Kroger N.
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [Abstract] [Full Text] [Related]

  • 43. Autoimmune pancytopenia following allogeneic bone marrow transplantation.
    Klumpp TR, Caligiuri MA, Rabinowe SN, Soiffer RJ, Murray C, Ritz J.
    Bone Marrow Transplant; 1990 Dec; 6(6):445-7. PubMed ID: 1965793
    [Abstract] [Full Text] [Related]

  • 44. Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
    Millot F, Esperou H, Bordigoni P, Dalle JH, Michallet M, Michel G, Bourhis JL, Kuenz M, Blaise D, Garban F, Plouvier E, Rome A, Guilhot J, Guilhot F.
    Bone Marrow Transplant; 2003 Nov; 32(10):993-9. PubMed ID: 14595387
    [Abstract] [Full Text] [Related]

  • 45. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
    Novotny JR, Rosenthal C, Elmaagacli AH, Dürig J, Beelen DW, Dührsen U.
    Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
    [Abstract] [Full Text] [Related]

  • 46. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y, Yoshihara S, Hoshida Y, Inoue T, Fujioka T, Ikegame K, Kawakami M, Masuda T, Aozasa K, Kawase I, Ogawa H.
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [Abstract] [Full Text] [Related]

  • 47. Donor cell derived acute myeloid leukemia after allogeneic cord blood transplantation in a patient with adult T-cell lymphoma.
    Matsunaga T, Murase K, Yoshida M, Fujimi A, Iyama S, Kuribayashi K, Sato T, Kogawa K, Hirayama Y, Sakamaki S, Kohda K, Niitsu Y.
    Am J Hematol; 2005 Aug; 79(4):294-8. PubMed ID: 16044441
    [Abstract] [Full Text] [Related]

  • 48. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ, Li J, Tan EX, Zhang GC, Wu XY, Peng AH, Zheng D, Zou WY, Hong WD, Luo SK.
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Mantle cell lymphoma 12 years after allogeneic bone marrow transplantation occurring simultaneously in recipient and donor.
    Christian B, Zhao W, Hamadani M, Sotomayor EM, Navarro W, Devine SM, Racke F, Blum KA.
    J Clin Oncol; 2010 Nov 01; 28(31):e629-32. PubMed ID: 20733121
    [No Abstract] [Full Text] [Related]

  • 51. [The molecular characteristics of T-cell immune reconstitution in leukemia patients after allogeneic hematopoietic stem cell transplantation].
    Fu YW, Wu DP, Sun AN, Feng YF, Chang WR, Zhu ZL, Zhu P.
    Zhonghua Xue Ye Xue Za Zhi; 2007 May 01; 28(5):312-7. PubMed ID: 17877159
    [Abstract] [Full Text] [Related]

  • 52. Graft-versus-leukemia effects from donor lymphocyte infusion after nonmyeloablative allogeneic bone marrow transplantation in mice.
    Du B, Li DP, Xu KL, Pan XY.
    Chin Med J (Engl); 2005 Mar 20; 118(6):474-9. PubMed ID: 15788128
    [Abstract] [Full Text] [Related]

  • 53. Leukemic relapse in the central nervous system after allogeneic stem cell transplantation with complete remission in the bone marrow and donor-type chimerism: report of two cases.
    Ohashi H, Kato C, Fukami S, Saito H, Hamaguchi M.
    Am J Hematol; 2005 Jun 20; 79(2):142-6. PubMed ID: 15929112
    [Abstract] [Full Text] [Related]

  • 54. T-cell large granular lymphocytic leukemia occurring after autologous peripheral blood stem cell transplantation.
    Narumi H, Kojima K, Matsuo Y, Shikata H, Sekiya K, Niiya T, Bando S, Niiya H, Azuma T, Yakushijin Y, Sakai I, Yasukawa M, Fujita S.
    Bone Marrow Transplant; 2004 Jan 20; 33(1):99-101. PubMed ID: 14704662
    [Abstract] [Full Text] [Related]

  • 55. Reconstitution of T cell subset repertoire diversity following multiple antigen-mismatched bone marrow transplantation.
    Friedman TM, Azhipa O, Zilberberg J, Tkachuk Y, Hsu JW, Rowley SD, Goldberg SL, Korngold R, Pecora AL, Preti RA.
    Biol Blood Marrow Transplant; 2006 Oct 20; 12(10):1092-5. PubMed ID: 17084373
    [No Abstract] [Full Text] [Related]

  • 56. Rapid helper T-cell recovery above 200 x 10 6/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation.
    Kim DH, Sohn SK, Won DI, Lee NY, Suh JS, Lee KB.
    Bone Marrow Transplant; 2006 Jun 20; 37(12):1119-28. PubMed ID: 16699530
    [Abstract] [Full Text] [Related]

  • 57. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.
    Hossain MS, Roback JD, Lezhava L, Hillyer CD, Waller EK.
    Biol Blood Marrow Transplant; 2005 Mar 20; 11(3):169-80. PubMed ID: 15744235
    [Abstract] [Full Text] [Related]

  • 58. Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph+ chronic myeloid leukemia.
    Kraut L, Trebeljahr G, Thiele B, Fauser AA.
    Bone Marrow Transplant; 2005 Oct 20; 36(8):737. PubMed ID: 16086042
    [No Abstract] [Full Text] [Related]

  • 59. Flow cytometric detection of nonneoplastic antigenic polymorphisms of donor origin after allogeneic marrow transplant: a report of two cases.
    Wang L, Wells DA, Deeg HJ, Loken MR.
    Am J Clin Pathol; 2004 Jul 20; 122(1):135-40. PubMed ID: 15272542
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.